Type / Class
Equity / Common Stock, par value $0.001 per share
Total 13F shares
18,503,424
Share change
+4,444,480
Total reported value
$134,518,808
Price per share
$7.27
Number of holders
48
Value change
+$32,318,988
Number of buys
37
Number of sells
7

Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q2 2016

As of 30 Jun 2016, GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,503,424 shares. The largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, BVF INC/IL, FRANKLIN RESOURCES INC, SPHERA FUNDS MANAGEMENT LTD., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, Cormorant Asset Management, LLC, BlackRock Fund Advisors, and Candriam Luxembourg S.C.A.. This page lists 48 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.